SCHEMBL21976478

SCHEMBL21976478

O=C(NO)c1ccc2c(c1)NC(c1c[nH]c3ccccc13)N2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.42
HDAC1 Q13547 5/20 0.42
HDAC6 Q9UBN7 5/20 0.42
AR P10275 1/20 0.40
CCR2 P41597 2/20 0.40
HDAC2 Q92769 2/20 0.40
HDAC3 O15379 1/20 0.40
HDAC8 Q9BY41 3/20 0.40
HDAC4 P56524 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40
PDE1C Q14123 1/20 0.39
IDH1 O75874 3/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
POLB P06746 1/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21976469 0.80 HDAC6 (0.47) ALOX5HDAC1HDAC6HDAC2HDAC3
SCHEMBL21976229 0.78 GAA (0.46) ALOX5HDAC1HDAC6HDAC2HDAC3
SCHEMBL21976956 0.76 USP2 (0.46) HDAC1HDAC6HDAC2HDAC3HDAC8
SCHEMBL21976480 0.76 HDAC6 (0.50) ALOX5HDAC1HDAC6ARHDAC2
SCHEMBL5079028 0.74 IDO1 (0.55) HDAC1HDAC6HDAC2HDAC3HDAC8
SCHEMBL5082100 0.74 IDO1 (0.55) HDAC1HDAC6HDAC2HDAC3HDAC8
SCHEMBL21976208 0.72 PBRM1 (0.44) ALOX5HDAC1HDAC6HDAC8
SCHEMBL21976232 0.72 SMPD1 (0.45) HDAC1HDAC6HDAC2HDAC8GAA
SCHEMBL10246978 0.71 KDM4E (0.44) HDAC1HDAC6CCR2HDAC2HDAC3
SCHEMBL10247090 0.71 HDAC8 (0.48) HDAC1HDAC6CCR2HDAC8POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3294715-B1 BENZIMIDAZOLE DERIVATES USEFUL AS INHIBITORS OF MAMMALIAN HISTONE DEACETYLASE ACTIVITY KANCERA AB (SE) 2020-05-06 EP disclosed